Sibannac, Inc. Provides New Shareholder Update
Scottsdale, Arizona--(Newsfile Corp. - February 15, 2024) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
Scottsdale, Arizona--(Newsfile Corp. - February 15, 2024) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
Following the VHA's Expansion of Get Well Solutions Across 13,000 Inpatient Beds, Recent Findings Have Underscored a Dramatic Enhancement in...
CHARLOTTESVILLE, VA / ACCESSWIRE / February 15, 2024 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)(NASDAQ:ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical...
Canalevia®-CA1 is currently FDA conditionally approved for treatment of CID in dogs and is the first and only treatment for...
Publication Details Positive Results of Clinical Study PF614-102SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Ensysce Biosciences, Inc....
Non-opioid drug candidate from Tonix lowered pain and also improved sleep and fatigueLatest Phase 3 trial achieved primary endpoint (p=0.00005)Potential...
DURHAM, NC / ACCESSWIRE / February 15, 2024 / Vogenx, Inc., a clinical-stage developer of novel therapeutics for the treatment...
SHELTON, CT / ACCESSWIRE / February 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum...
– Findings demonstrate significant reduction in pain and opioid consumption through 96 hours versus active comparator – – Significantly greater...
Carlsbad, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on...
RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will...
CAMBRIDGE, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Designation Based on Pre-Clinical Data and Initial Clinical Data from the Company's MAvERIC-Pilot Phase II StudyThis is a Designated News...
LONDON, UK / ACCESSWIRE / February 15, 2024 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, "Poolbeg" or the "Company"), a biopharmaceutical company...
UPPSALA, SWEDEN / ACCESSWIRE / February 15, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Press release: Uppsala, February 15, 2024. Senzime AB (publ):s...
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), is announcing today that its Vice President and Chief Financial Officer, Jay Saccaro, will be...
Conference Call Scheduled for Thursday, February 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite...
Q2 2024 operating income of $2.4 millionQ2 2024 net loss of $0.2 million and adjusted EBITDA1 of $5.1 millionQ2 2024...
Accomplished executive brings 20+ years of experience leading transformative data intelligence initiatives across industries.AUSTIN, Texas--(BUSINESS WIRE)--ESO, a leading data and...
MORTSEL, BELGIUM / ACCESSWIRE / February 14, 2024 / In our unwavering commitment to providing cutting-edge clinical technology in Latin...